Quick Answer
Antihistamines block H1 receptors throughout the body to prevent histamine from causing allergy symptoms. Second and third-generation antihistamines (Zyrtec, Claritin, Allegra) are preferred for daily use because they do not cross the blood-brain barrier and cause little to no sedation, unlike first-generation Benadryl.
Key Takeaways
- First-generation antihistamines (Benadryl) cause significant sedation and cognitive impairment — not recommended for daily use
- Second-generation antihistamines (Zyrtec, Claritin, Allegra) are non-sedating and safe for long-term daily use
- Antihistamines are highly effective for sneezing, itching, and runny nose but provide only modest relief for nasal congestion
- Nasal corticosteroid sprays (Flonase, Nasacort) are now first-line over antihistamines for allergic rhinitis by major guidelines
- Antihistamines cannot treat anaphylaxis — epinephrine is the only appropriate first-line treatment for life-threatening reactions
- Cetirizine is the most potent of the common OTC options; fexofenadine has the lowest sedation risk
The Role of Histamine
During an allergic reaction, the immune system triggers mast cells to release histamine. This chemical binds to H1 receptors throughout the body, causing blood vessels to expand, mucus production to increase, and skin to itch. Antihistamines work by blocking these H1 receptors, preventing histamine from exerting its effects.
First-Generation Antihistamines
Developed in the mid-20th century, these medications (e.g., Diphenhydramine, Chlorpheniramine) are highly lipophilic, allowing them to easily cross the blood-brain barrier. While effective at blocking H1 receptors, their central nervous system penetration causes significant adverse effects.
- Pros: Fast-acting, highly effective, often used in acute allergic reactions (hives) or as a sleep aid.
- Cons: Pronounced sedation, cognitive impairment, dry mouth, blurred vision, and urinary retention (due to anticholinergic properties). Their short half-life requires multiple daily doses.
Second and Third-Generation Antihistamines
Newer generation antihistamines (e.g., Cetirizine, Loratadine, Fexofenadine) were engineered to be larger molecules that do not easily cross the blood-brain barrier. This design significantly reduces sedative effects while maintaining peripheral H1 blockade.
Third-generation antihistamines (e.g., Levocetirizine, Desloratadine, Fexofenadine) are active enantiomers or metabolites of second-generation drugs, offering potentially greater efficacy with even fewer side effects.
| Generic Name | Common Brand | Generation | Sedation Risk |
|---|---|---|---|
| Diphenhydramine | Benadryl | 1st | High |
| Cetirizine | Zyrtec | 2nd | Low-Moderate |
| Loratadine | Claritin | 2nd | Very Low |
| Fexofenadine | Allegra | 3rd | Non-sedating |
| Levocetirizine | Xyzal | 3rd | Low-Moderate |
Clinical Considerations for Use
When choosing an antihistamine, clinicians consider the patient's age, comorbidities, concurrent medications, and the timing of symptoms. For chronic daily control of allergic rhinitis, second or third-generation oral antihistamines are preferred due to their favorable safety profile and once-daily dosing.
Note: Antihistamines are excellent for treating rhinorrhea, sneezing, and pruritus, but they are less effective at resolving severe nasal congestion. In cases of predominant congestion, they are often combined with a decongestant or replaced by an intranasal corticosteroid.